Cytosorbents' (CTSO) CEO Phillip Chan on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/10/21
CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare ConferencePRNewsWire • 02/16/21
National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac SurgeryPRNewsWire • 02/04/21
CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory AffairsPRNewsWire • 01/21/21
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical CarePRNewsWire • 01/19/21
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and MarketingPRNewsWire • 12/17/20
Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock StudyPRNewsWire • 12/09/20
CytoSorbents Launches International Campaign to Raise $100,000 for the Global Humanitarian Organization, CAREPRNewsWire • 12/02/20
CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 PatientsPRNewsWire • 11/25/20
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
The U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize Development of HemoDefend-BGA™ for Life-saving Universal PlasmaPRNewsWire • 10/09/20
CytoSorb Achieves Registration in Brazil and Is Now Commercially Available To Treat Cytokine Storm in COVID-19 Infection and Other ConditionsPRNewsWire • 09/21/20
CytoSorbents Announces the "CytoSorb Therapy in COVID-19 ICU Patients" (CTC) Registry Is Actively EnrollingPRNewsWire • 09/08/20
CytoSorbents Partners with InvoSurg and Surgical Partners to Commercialize CytoSorb® in the U.S. Northeast, Mid-Atlantic, and Florida under FDA Emergency Use Authorization for COVID-19PRNewsWire • 08/17/20
